A novel TP53 mutation in a Li-Fraumeni syndrome family
Author Information
Author(s): JM Varley, G McGown, M Thomcroft, GRM White, KJ Tricker, AM Kelsey, JM Birch, DGR Evans
Primary Institution: CRC Department of Cancer Genetics, Paterson Institute for Cancer Research
Hypothesis
Is there a splice acceptor mutation in the TP53 gene in a Li-Fraumeni syndrome family?
Conclusion
The child with Wilms' tumour in the family was not a mutation carrier, suggesting that the clustering of tumours in this family is not due to a germline TP53 mutation.
Supporting Evidence
- A splice acceptor mutation in intron 3 of TP53 was detected in the family.
- The child with Wilms' tumour was shown not to be a mutation carrier.
- Two aberrant transcripts were produced due to the mutation.
- Previous studies indicated that Wilms' tumours may occur at an increased frequency in patients with Li-Fraumeni syndrome.
Takeaway
This study looked at a family with a rare cancer syndrome and found a mutation in a gene related to cancer, but one child with a specific type of cancer did not have that mutation.
Methodology
DNA from family members was screened for a germline TP53 mutation by direct sequencing of all exons and RT-PCR analysis was performed on RNA extracted from lymphocytes.
Limitations
The study may not have included all cancer-affected individuals in the family for mutation screening.
Participant Demographics
The family included individuals with various cancers, including osteosarcoma, Wilms' tumour, and others.
Want to read the original?
Access the complete publication on the publisher's website